Biddeford-based startup Prapela Inc. is seeking regulatory OK for use of a technology-enabled bassinet pad as a complementary treatment for newborns in opioid withdrawal.
Clearance by U.S. Food and Drug Administration would make Prapela’s product the first such device to treat newborns diagnosed with neonatal opioid withdrawal syndrome, the company said. Read more
FORT KENT, Maine — Fort Kent middle schoolers are the state’s first students to learn at the newly unveiled Maine Mobile Biolab, a 50-foot,...
Anew medical lab training facility on the campus of University of Maine Augusta is nearly six times larger than an off-campus space...
The University of New England has received a grant from the Maine Department of Inland Fisheries and Wildlife to study one...